PPD

General Information
Business:

 

We are a leading provider of drug development services to the biopharmaceutical industry, focused on helping our customers bring their new medicines to patients around the world. We have been in the drug development services business for more than 30 years, providing a comprehensive suite of clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, as well as other industry participants. Over that time, we have developed a track record of consistent quality, delivery and continuous innovation that has enabled us to grow faster than our underlying market over the past five years and deliver strong financial results.

Industry: COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Employees: 23000
Founded: 2017
Contact Information
Address 929 North Front Street, Wilmington, NC 28401, US
Phone Number (910) 251-0081
Web Address http://www.ppdi.com
View Prospectus: PPD
Financial Information
Market Cap $9164.5mil
Revenues $3962.8 mil (last 12 months)
Net Income $84.5 mil (last 12 months)
IPO Profile
Symbol PPD
Exchange NASDAQ
Shares (millions): 60.0
Price range $27.00 - $27.00
Est. $ Volume $1620.0 mil
Manager / Joint Managers Barclays/ J.P. Morgan/ Morgan Stanley/ Goldman Sachs/ BofA Securities/ Credit Suisse/ Jefferies/ UBS Investment Bank/ Citigroup/ Deutsche Bank Securities/ Evercore ISI/ HSBC/ Mizuho Securities/ Baird/ William Blair
CO-Managers BofA Securities/ Credit Suisse/ Jefferies/ UBS Investment Bank/ Citigroup/ Deutsche Bank Securities/ Evercore ISI/ HSBC/ Mizuho Securities/ Baird/ William Blair/ Drexel Hamilton
Expected To Trade: 2/6/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change